The U.S. Food and Drug Administration ... animal testing with a new model based on artificial intelligence (AI). This approach, which will be applied to the development of monoclonal antibody ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

The global biosimulation market, valued at approximately USD 3.1 billion in 2022, is on track to experience significant growth over the next decade. Projected to expand at a compound annual growth ...

In an unexpected move, the U.S. Food and Drug Administration ... R&D costs and, eventually, the prices for prescription drugs. The agency will encourage researchers to use computer modeling ...

Our MSc Model-based Drug Development course provides the knowledge and skills ... methods are so highly valued by industry and regulatory authorities as effective, cost-saving, decision-making tools.

The Food and Drug ... the cost of research and development. As part of this move, the FDA is releasing a roadmap for alternative methodologies that will encourage the use of computer modeling ...